- Home
- PFE
PFE
Pfizer Inc.
as 12-20-2024 4:00pm EST
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 166.8B | IPO Year: | N/A |
| Target Price: | $32.31 | AVG Volume (30 days): | 45.2M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.74 | EPS Growth: | -59.45 |
| 52 Week Low/High: | $24.48 - $31.54 | Next Earning Date: | 01-28-2025 |
| Revenue: | $59,375,000,000 | Revenue Growth: | -14.29% |
| Revenue Growth (this year): | 8.74% | Revenue Growth (next year): | 0.38% |
Stock Insider Trading Activity of Pfizer Inc. (PFE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gottlieb Scott | PFE | Director | Oct 30 '24 | Buy | $28.24 | 1,000 | $28,240.00 | 10,000 |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Insider Monkey
4 hours ago
Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts
Simply Wall St.
6 hours ago
The three-year loss for Pfizer (NYSE:PFE) shareholders likely driven by its shrinking earnings
Motley Fool
8 hours ago
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025
Motley Fool
9 hours ago
My Top 10 Stocks to Buy for 2025
Morningstar Research
18 hours ago
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
MT Newswires
21 hours ago
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
MT Newswires
a day ago
Sector Update: Health Care
MT Newswires
a day ago
Pfizer Drug Combination to Treat Colorectal Cancer Cleared by FDA
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.